Please provide your email address to receive an email when new articles are posted on . Researchers have proposed a machine-learning algorithm for personalized treatment selection in patients with ...

BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...

WEST LAFAYETTE, Ind. — A Purdue University professor and several international researchers have developed a new method and algorithm that can predict the recurrence of prostate cancer in patients ...

June 22, 2010 (Boca Raton, Florida) — Measuring the coefficient of variation (CV) in the ratio between the level of lithium in the serum and the dose of lithium (L/D ratio) that has actually been ...

Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...